FULC
Fulcrum Therapeutics, Inc. · Healthcare
Director Robert J Gould sold $2.3M of Fulcrum Therapeutics, Inc.
Sold$2,276,684
$24.16Price
94,251Shares
−16%Stake
What FULC did after the filing
- The stock from Tue, Apr 5 close, $23.87
- −64.4%
- S&P 500, same days
- −13.1%
Measured over 30 trading days, to the May 18 close.
Traded Fri, Apr 1. Filed Tue, Apr 5, 3:00 PM ET, during the session. Returns use the Apr 5 close and the May 18 close. Not investment advice.